Clinical Trial Research
Cardiome Announces Upcoming Presentation of Results of Phase 2b Clinical Trial of Vernakalant (Oral) At the European Society of Cardiology Congress 2009
Published in Drug Law Weekly, September 8th, 2009
Cardiome Pharma Corp. (NASDAQ: CRME)(NASDAQ:/)(NASDAQ:TSX:)(NASDAQ:COM) announced that Dr. Christian Torp-Pedersen is scheduled to present detailed findings from the Phase 2b clinical trial of vernakalant (oral) at the European Society of Cardiology (ESC) Congress 2009, being held in Barcelona, Spain from August 29 to September 2, 2009. The presentation, titled "Oral vernakalant for the prevention of atrial fibrillation recurrence post-cardioversion," is scheduled for Monday, August 31, 2009 at 4:45pm local time.
Positive top-line results from the Phase 2b trial were originally announced in July 2008. The 735-patient double-blind, placebo-controlled, randomized,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-09-08)
More Articles from Drug Law Weekly
- Chicago Metropolis 2020
Crime Reduction Act of 2009 to Reduce Prison Costs, Rehabilitate Offenders and Keep Communities Safe - Drug Discovery and Design
New findings from J.B. Tucker and co-researchers in the area of drug discovery and design described - Drug Discovery and Design
Research on drug discovery and design described by scientists at University of Texas - Epidemics
American Legacy Foundation(R) Remembers Senator Edward M. Kennedy: a Crusader for Public Health - HealthLeaders-InterStudy
Consolidation Among Chicago Physicians Likely to Increase - Life Sciences
University of Otago details research in life sciences in children - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
